Notice of Request for Information by the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 32335-32336 [2016-12043]

Download as PDF 32335 Federal Register / Vol. 81, No. 99 / Monday, May 23, 2016 / Notices NHANES, including questions about food security and nutrition program participation, dietary supplement use, and weight history/self-image/related behavior. In 2017–2018, we also plan to conduct a Dietary Supplement Imaging pilot study, as well as implement multimode screening and electronic consent procedures in NHANES. The consent for birth certificate linkage that had been included in previous NHANES will be dropped from NHANES 2017–2018. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Individuals Individuals Individuals Individuals Individuals in in in in in households households households households households Number of responses per respondent Number of respondents Form name Average burden per response (in hours) Total burden hours 14,410 1,404 2,000 1,200 2,880 1 1 1 1 1 2.5 30/60 30/60 25 10/60 36,025 702 1,000 30,000 480 2,520 1 10/60 420 2,160 1 10/60 360 1,800 1 10/60 300 5,000 1 20/60 1,667 Individuals in households NHANES Questionnaire ...................................... Blood Pressure Methodology Study Phase 1 ..... Blood Pressure Methodology Study Phase 2 ..... Ambulatory Blood Pressure Pilot Study .............. Oral HPV rinse Follow-up Study 6 months (estimated 80% of original sample of 3600). Oral HPV rinse Follow-up Study 12 Months (estimated 70% of original sample). Oral HPV rinse Follow-up Study 18 months (estimated 60% of original sample). Oral HPV rinse Follow-up Study 24 Months (estimated 50% of original sample). Flexible Consumer Behavior Survey Phone Follow-Up. Special Studies .................................................... 3,500 1 3 10,500 Total ........................ .............................................................................. ........................ ........................ ........................ 81,454 Individuals in households Individuals in households Individuals in households Individuals in households Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–12009 Filed 5–20–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Request for Information by the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: sradovich on DSK3TPTVN1PROD with NOTICES Comments must be received by 11:59 p.m. on June 22, 2016 to be considered. DATES: VerDate Sep<11>2014 18:25 May 20, 2016 Jkt 238001 Individuals are encouraged to submit their responses through one of the following methods. Utilization of the online form available on www.hhs.gov/ash/carb is the preferred method of submission. Should you choose to send in your responses via email, please be sure to include the question number(s) in the subject line. Do not include in your response information of a confidential nature, such as sensitive personal information or proprietary information. Responses to this notice are not offers and cannot be accepted by the federal government to form a binding contract or issue a grant. Please be aware that your comments will not affirmatively be posted ADDRESSES: The Presidential Advisory Council on Combating AntibioticResistant Bacteria (Advisory Council) requests information from the general public and stakeholders related to efforts and strategies to combat antibiotic-resistance. In the process of developing their report, Initial Assessments of the National Action Plan for Combating Antibiotic-Resistant Bacteria, the Advisory Council followed the framework of the National Action Plan for Combating Antibiotic Resistant Bacteria (Action Plan) to hear about a wide range of ongoing and planned activities by the federal government, SUMMARY: including some stakeholders/sectors relevant to this overall effort. This Request for Information (RFI) offers the opportunity for interested individuals, organizations, associations, industries, and others, to provide their feedback. Responses to the questions must be received by 11:59 p.m. on June 22, 2016 to be considered. The questions are also available through an online form on the Advisory Council Web page at www.hhs.gov/ash/carb. Individuals who wish to send in their responses via email should send an email to CARB@ hhs.gov, indicating the question number(s) for which they are responding. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 publicly, however they may be made available to the public, in part or in full, subject to applicable laws and regulations. • Online Form: www.hhs.gov/ash/ carb. Online submissions will receive an automatic confirmation acknowledging receipt of your response, but will not receive individualized feedback on any suggestions. • Email: CARB@hhs.gov. Please indicate the question number(s) in the subject line of your email. Email submissions will receive an electronic confirmation acknowledging receipt of your response, but will not receive individualized feedback on any suggestions. SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 18, 2014, authority was given to the Secretary of Health and Human Services (HHS) to establish the Advisory Council, in consultation with the Secretaries of Defense and Agriculture. Activities of the Advisory Council are governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The Advisory Council will provide advice, information, and recommendations to the Secretary of HHS regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for Combating Antibiotic-Resistant E:\FR\FM\23MYN1.SGM 23MYN1 sradovich on DSK3TPTVN1PROD with NOTICES 32336 Federal Register / Vol. 81, No. 99 / Monday, May 23, 2016 / Notices Bacteria and the Action Plan. The Advisory Council shall function solely for advisory purposes. In carrying out its mission, the Advisory Council will provide advice, information, and recommendations to the Secretary regarding programs and policies intended to preserve the effectiveness of antibiotics by optimizing their use; advance research to develop improved methods for combating antibiotic resistance and conducting antibiotic stewardship; strengthen surveillance of antibioticresistant bacterial infections; prevent the transmission of antibiotic-resistant bacterial infections; advance the development of rapid point-of-care and agricultural diagnostics; further research on new treatments for bacterial infections; develop alternatives to antibiotics for agricultural purposes; maximize the dissemination of up-todate information on the appropriate and proper use of antibiotics to the general public and human and animal healthcare providers; and improve international coordination of efforts to combat antibiotic resistance. In response to their mission, the Advisory Council recently released their first report, Initial Assessments of the National Action Plan for Combating AntibioticResistant Bacteria, at their second public meeting held on March 30–31, 2016, in Washington, DC. Background: In the process of developing their report, the Advisory Council followed the framework of the Action Plan to hear about a wide range of ongoing and planned activities by the federal government, including some stakeholders/sectors relevant to this overall effort. Acknowledging that there are others who the Advisory Council would like to hear from, they are seeking that information through this RFI. The purpose of the questions posed in this RFI is to gain additional information from the public on the subject matter in several areas addressed in the Action Plan. The responses gathered from the RFI will be reviewed by the members of the Advisory Council and will be taken into consideration as they move forward with their activities. The responses provided are for the Advisory Council’s informational purposes only. Response to this RFI is voluntary. Responders are free to address any or all of the questions below. Request for Information: To solicit additional information from the public, including individuals, organizations, associations, and industries involved in combating antibiotic-resistance, the Advisory Council seeks responses on the following requests for information: VerDate Sep<11>2014 18:25 May 20, 2016 Jkt 238001 1. Describe how organizations are influencing curricula regarding primary prevention (antibiotic stewardship, infection prevention, and control). Please include information about certification examinations, requirements, and continuing education, if relevant. 2. Describe how healthcare organizations can best: (a) Educate and provide feedback to providers in clinics/ facilities about infectious diseases diagnostic testing, optimal antibiotic prescribing, and infection prevention; where relevant, please include information about what incentives and disincentives these organizations have in place with the goal of improving antibiotic prescribing (e.g., using clinical decision support) and prevent spread of resistant infections; and, (b) encourage and/or incentivize providers to report antibiotic use and resistance data for all patient populations. 3. Please provide examples of successful behavior change models that can be applied to preventive strategies, such as infection control and antibiotic stewardship. 4. Please provide information on the best ways to collect data on antibiotic use [and resistance] in animal agriculture through public-private collaborations. Your response can include information on the types of data to be collected, including the method of collection, and the metrics for reporting the data. If helpful, please cite sample models as examples to depict your answer. 5. Please provide information on the different resources that exist to promote the understanding of how antibiotics are being used in humans and animals in different parts of the world. Your response can include information on the types of support to connect with such resources, as appropriate (examples include public-private partnerships, strategic resourcing, or other means). More information can be found at www.hhs.gov/ash/carb. Dated: May 18, 2016. Bruce Gellin, Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Deputy Assistant Secretary for Health. [FR Doc. 2016–12043 Filed 5–20–16; 8:45 am] BILLING CODE 4150–44–P PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Neurotransporters, Receptors, and Calcium Signaling Study Section. Date: June 16–17, 2016. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Westin Crystal City, 1800 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Peter B. Guthrie, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD 20892, (301) 435– 1239, guthriep@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Molecular and Cellular Endocrinology Study Section. Date: June 16–17, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westgate Hotel, 1055 2nd Ave., San Diego, CA 92101. Contact Person: John Bleasdale, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 20892, 301–435– 4514, bleasdaleje@csr.nih.gov. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Gene and Drug Delivery Systems Study Section. Date: June 22–23, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Amy L. Rubinstein, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5152, MSC 7844, Bethesda, MD 20892, 301–408– 9754, rubinsteinal@csr.nih.gov. E:\FR\FM\23MYN1.SGM 23MYN1

Agencies

[Federal Register Volume 81, Number 99 (Monday, May 23, 2016)]
[Notices]
[Pages 32335-32336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12043]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Notice of Request for Information by the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria (Advisory Council) requests information from the 
general public and stakeholders related to efforts and strategies to 
combat antibiotic-resistance. In the process of developing their 
report, Initial Assessments of the National Action Plan for Combating 
Antibiotic-Resistant Bacteria, the Advisory Council followed the 
framework of the National Action Plan for Combating Antibiotic 
Resistant Bacteria (Action Plan) to hear about a wide range of ongoing 
and planned activities by the federal government, including some 
stakeholders/sectors relevant to this overall effort. This Request for 
Information (RFI) offers the opportunity for interested individuals, 
organizations, associations, industries, and others, to provide their 
feedback. Responses to the questions must be received by 11:59 p.m. on 
June 22, 2016 to be considered. The questions are also available 
through an online form on the Advisory Council Web page at www.hhs.gov/ash/carb. Individuals who wish to send in their responses via email 
should send an email to CARB@hhs.gov, indicating the question number(s) 
for which they are responding.

DATES: Comments must be received by 11:59 p.m. on June 22, 2016 to be 
considered.

ADDRESSES: Individuals are encouraged to submit their responses through 
one of the following methods. Utilization of the online form available 
on www.hhs.gov/ash/carb is the preferred method of submission. Should 
you choose to send in your responses via email, please be sure to 
include the question number(s) in the subject line. Do not include in 
your response information of a confidential nature, such as sensitive 
personal information or proprietary information. Responses to this 
notice are not offers and cannot be accepted by the federal government 
to form a binding contract or issue a grant. Please be aware that your 
comments will not affirmatively be posted publicly, however they may be 
made available to the public, in part or in full, subject to applicable 
laws and regulations.
     Online Form: www.hhs.gov/ash/carb. Online submissions will 
receive an automatic confirmation acknowledging receipt of your 
response, but will not receive individualized feedback on any 
suggestions.
     Email: CARB@hhs.gov. Please indicate the question 
number(s) in the subject line of your email. Email submissions will 
receive an electronic confirmation acknowledging receipt of your 
response, but will not receive individualized feedback on any 
suggestions.

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of Health and Human 
Services (HHS) to establish the Advisory Council, in consultation with 
the Secretaries of Defense and Agriculture. Activities of the Advisory 
Council are governed by the provisions of Public Law 92-463, as amended 
(5 U.S.C. App.), which sets forth standards for the formation and use 
of federal advisory committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant

[[Page 32336]]

Bacteria and the Action Plan. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance. 
In response to their mission, the Advisory Council recently released 
their first report, Initial Assessments of the National Action Plan for 
Combating Antibiotic-Resistant Bacteria, at their second public meeting 
held on March 30-31, 2016, in Washington, DC.
    Background: In the process of developing their report, the Advisory 
Council followed the framework of the Action Plan to hear about a wide 
range of ongoing and planned activities by the federal government, 
including some stakeholders/sectors relevant to this overall effort. 
Acknowledging that there are others who the Advisory Council would like 
to hear from, they are seeking that information through this RFI. The 
purpose of the questions posed in this RFI is to gain additional 
information from the public on the subject matter in several areas 
addressed in the Action Plan. The responses gathered from the RFI will 
be reviewed by the members of the Advisory Council and will be taken 
into consideration as they move forward with their activities. The 
responses provided are for the Advisory Council's informational 
purposes only. Response to this RFI is voluntary. Responders are free 
to address any or all of the questions below.
    Request for Information: To solicit additional information from the 
public, including individuals, organizations, associations, and 
industries involved in combating antibiotic-resistance, the Advisory 
Council seeks responses on the following requests for information:
    1. Describe how organizations are influencing curricula regarding 
primary prevention (antibiotic stewardship, infection prevention, and 
control). Please include information about certification examinations, 
requirements, and continuing education, if relevant.
    2. Describe how healthcare organizations can best: (a) Educate and 
provide feedback to providers in clinics/facilities about infectious 
diseases diagnostic testing, optimal antibiotic prescribing, and 
infection prevention; where relevant, please include information about 
what incentives and disincentives these organizations have in place 
with the goal of improving antibiotic prescribing (e.g., using clinical 
decision support) and prevent spread of resistant infections; and, (b) 
encourage and/or incentivize providers to report antibiotic use and 
resistance data for all patient populations.
    3. Please provide examples of successful behavior change models 
that can be applied to preventive strategies, such as infection control 
and antibiotic stewardship.
    4. Please provide information on the best ways to collect data on 
antibiotic use [and resistance] in animal agriculture through public-
private collaborations. Your response can include information on the 
types of data to be collected, including the method of collection, and 
the metrics for reporting the data. If helpful, please cite sample 
models as examples to depict your answer.
    5. Please provide information on the different resources that exist 
to promote the understanding of how antibiotics are being used in 
humans and animals in different parts of the world. Your response can 
include information on the types of support to connect with such 
resources, as appropriate (examples include public-private 
partnerships, strategic resourcing, or other means).
    More information can be found at www.hhs.gov/ash/carb.

    Dated: May 18, 2016.
Bruce Gellin,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Deputy Assistant Secretary for Health.
[FR Doc. 2016-12043 Filed 5-20-16; 8:45 am]
 BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.